Indaptus Net Debt vs Short Long Term Debt Total Analysis

INDP Stock

USD 11.85 0.73 5.80%

Indaptus Therapeutics financial indicator trend analysis is infinitely more than just investigating Indaptus Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Indaptus Therapeutics is a good investment. Please check the relationship between Indaptus Therapeutics Net Debt and its Short Long Term Debt Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.

Net Debt vs Short Long Term Debt Total

Net Debt vs Short Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Indaptus Therapeutics Net Debt account and Short Long Term Debt Total. At this time, the significance of the direction appears to have no relationship.

The correlation between Indaptus Therapeutics' Net Debt and Short Long Term Debt Total is 0.07. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Short Long Term Debt Total in the same time period over historical financial statements of Indaptus Therapeutics, assuming nothing else is changed. The correlation between historical values of Indaptus Therapeutics' Net Debt and Short Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Indaptus Therapeutics are associated (or correlated) with its Short Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt Total has no effect on the direction of Net Debt i.e., Indaptus Therapeutics' Net Debt and Short Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

0.07

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Short Long Term Debt Total

Most indicators from Indaptus Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Indaptus Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.As of 07/16/2025, Issuance Of Capital Stock is likely to grow to about 5.8 M, while Selling General Administrative is likely to drop slightly above 5.9 M.

	2022	2023	2024	2025 (projected)
Total Operating Expenses	14.9M	16.4M	15.4M	14.2M
Cost Of Revenue	1.8K	1.3K	735.0	698.25

Total Operating Expenses Cost Of Revenue

Indaptus Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Short Term Investments	Inventory	Non Currrent Assets Other	Net Tangible Assets	Property Plant Equipment
Total Assets		0.04	0.37	0.56	0.99	0.7	-0.95	-0.47	0.8	0.95	0.68	0.97	0.28	-0.32	-0.28	0.55	0.42	0.47	0.98	-0.17	0.46	0.09	0.28	0.4	0.02	0.04
Short Long Term Debt Total	0.04		0.0	0.05	0.02	0.47	0.07	-0.15	-0.23	-0.03	0.37	-0.07	0.34	-0.7	0.29	-0.25	0.12	0.14	-0.05	0.85	0.46	0.07	0.42	0.02	-0.69	-0.69
Other Current Liab	0.37	0.0		0.85	0.28	0.44	-0.26	-0.92	0.1	0.27	0.61	0.23	0.79	-0.16	-0.12	-0.12	0.93	0.86	0.26	-0.14	0.36	-0.2	-0.01	0.79	-0.17	-0.2
Total Current Liabilities	0.56	0.05	0.85		0.47	0.42	-0.51	-0.8	0.47	0.53	0.59	0.47	0.63	-0.13	-0.33	0.08	0.81	0.94	0.49	0.05	0.13	-0.17	0.0	0.79	0.09	0.1
Total Stockholder Equity	0.99	0.02	0.28	0.47		0.68	-0.95	-0.39	0.8	0.95	0.64	0.98	0.21	-0.31	-0.27	0.58	0.33	0.37	0.98	-0.2	0.45	0.11	0.29	0.32	0.02	0.05
Property Plant And Equipment Net	0.7	0.47	0.44	0.42	0.68		-0.57	-0.6	0.43	0.57	0.96	0.54	0.54	-0.59	0.1	0.1	0.45	0.45	0.56	0.09	0.8	-0.09	0.33	0.54	-0.56	-0.55
Net Debt	-0.95	0.07	-0.26	-0.51	-0.95	-0.57		0.34	-0.82	-1.0	-0.52	-0.97	-0.12	0.24	0.42	-0.56	-0.3	-0.39	-0.97	0.22	-0.32	0.11	-0.19	-0.25	-0.14	-0.2
Retained Earnings	-0.47	-0.15	-0.92	-0.8	-0.39	-0.6	0.34		-0.18	-0.35	-0.74	-0.3	-0.87	0.23	0.09	-0.08	-0.96	-0.82	-0.35	0.09	-0.57	0.22	0.03	-0.81	0.23	0.27
Accounts Payable	0.8	-0.23	0.1	0.47	0.8	0.43	-0.82	-0.18		0.82	0.46	0.81	-0.05	0.06	-0.41	0.56	0.1	0.33	0.8	-0.24	0.05	-0.03	0.0	0.36	0.4	0.45
Cash	0.95	-0.03	0.27	0.53	0.95	0.57	-1.0	-0.35	0.82		0.53	0.97	0.13	-0.26	-0.42	0.55	0.32	0.41	0.97	-0.18	0.32	-0.11	0.2	0.26	0.13	0.19
Non Current Assets Total	0.68	0.37	0.61	0.59	0.64	0.96	-0.52	-0.74	0.46	0.53		0.5	0.68	-0.5	0.04	0.1	0.6	0.61	0.52	0.04	0.7	-0.11	0.26	0.76	-0.45	-0.46
Cash And Short Term Investments	0.97	-0.07	0.23	0.47	0.98	0.54	-0.97	-0.3	0.81	0.97	0.5		0.1	-0.22	-0.34	0.6	0.28	0.36	1.0	-0.21	0.32	0.14	0.25	0.23	0.16	0.19
Net Receivables	0.28	0.34	0.79	0.63	0.21	0.54	-0.12	-0.87	-0.05	0.13	0.68	0.1		-0.48	0.22	-0.07	0.89	0.68	0.15	0.04	0.62	-0.14	0.24	0.75	-0.42	-0.42
Common Stock Shares Outstanding	-0.32	-0.7	-0.16	-0.13	-0.31	-0.59	0.24	0.23	0.06	-0.26	-0.5	-0.22	-0.48		-0.16	0.04	-0.26	-0.17	-0.24	-0.39	-0.61	0.1	-0.65	-0.1	0.79	0.7
Non Current Liabilities Total	-0.28	0.29	-0.12	-0.33	-0.27	0.1	0.42	0.09	-0.41	-0.42	0.04	-0.34	0.22	-0.16		-0.55	-0.06	-0.17	-0.33	0.05	0.32	0.28	0.3	-0.13	-0.35	-0.37
Other Current Assets	0.55	-0.25	-0.12	0.08	0.58	0.1	-0.56	-0.08	0.56	0.55	0.1	0.6	-0.07	0.04	-0.55		0.06	-0.03	0.61	-0.28	0.11	0.15	-0.04	0.06	0.36	0.36
Other Stockholder Equity	0.42	0.12	0.93	0.81	0.33	0.45	-0.3	-0.96	0.1	0.32	0.6	0.28	0.89	-0.26	-0.06	0.06		0.83	0.32	-0.09	0.5	-0.17	0.03	0.74	-0.18	-0.19
Total Liab	0.47	0.14	0.86	0.94	0.37	0.45	-0.39	-0.82	0.33	0.41	0.61	0.36	0.68	-0.17	-0.17	-0.03	0.83		0.39	0.09	0.25	-0.14	0.02	0.78	-0.01	0.0
Total Current Assets	0.98	-0.05	0.26	0.49	0.98	0.56	-0.97	-0.35	0.8	0.97	0.52	1.0	0.15	-0.24	-0.33	0.61	0.32	0.39		-0.21	0.35	0.13	0.26	0.26	0.14	0.17
Short Term Debt	-0.17	0.85	-0.14	0.05	-0.2	0.09	0.22	0.09	-0.24	-0.18	0.04	-0.21	0.04	-0.39	0.05	-0.28	-0.09	0.09	-0.21		-0.05	0.14	0.21	-0.08	-0.38	-0.38
Common Stock	0.46	0.46	0.36	0.13	0.45	0.8	-0.32	-0.57	0.05	0.32	0.7	0.32	0.62	-0.61	0.32	0.11	0.5	0.25	0.35	-0.05		-0.06	0.34	0.27	-0.63	-0.63
Short Term Investments	0.09	0.07	-0.2	-0.17	0.11	-0.09	0.11	0.22	-0.03	-0.11	-0.11	0.14	-0.14	0.1	0.28	0.15	-0.17	-0.14	0.13	0.14	-0.06		0.25	-0.13	0.05	-0.03
Inventory	0.28	0.42	-0.01	0.0	0.29	0.33	-0.19	0.03	0.0	0.2	0.26	0.25	0.24	-0.65	0.3	-0.04	0.03	0.02	0.26	0.21	0.34	0.25		-0.03	-0.34	-0.33
Non Currrent Assets Other	0.4	0.02	0.79	0.79	0.32	0.54	-0.25	-0.81	0.36	0.26	0.76	0.23	0.75	-0.1	-0.13	0.06	0.74	0.78	0.26	-0.08	0.27	-0.13	-0.03		-0.09	-0.11
Net Tangible Assets	0.02	-0.69	-0.17	0.09	0.02	-0.56	-0.14	0.23	0.4	0.13	-0.45	0.16	-0.42	0.79	-0.35	0.36	-0.18	-0.01	0.14	-0.38	-0.63	0.05	-0.34	-0.09		0.98
Property Plant Equipment	0.04	-0.69	-0.2	0.1	0.05	-0.55	-0.2	0.27	0.45	0.19	-0.46	0.19	-0.42	0.7	-0.37	0.36	-0.19	0.0	0.17	-0.38	-0.63	-0.03	-0.33	-0.11	0.98

Click cells to compare fundamentals

Indaptus Therapeutics Account Relationship Matchups

Indaptus Therapeutics fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	1.8M	40.6M	28.1M	14.9M	7.3M	7.0M
Other Current Liab	1.9M	498.7K	1.8M	1.8M	2.1M	2.1M
Total Current Liabilities	2.0M	4.6M	3.4M	2.8M	3.4M	3.4M
Total Stockholder Equity	(237.7K)	35.9M	24.6M	12.1M	3.9M	3.7M
Property Plant And Equipment Net	1.3K	172.9K	81.3K	173.9K	82.2K	78.1K
Net Debt	(1.6M)	(39.0M)	(9.5M)	(13.2M)	(5.7M)	(6.0M)
Retained Earnings	(8.0M)	(15.7M)	(30.0M)	(45.4M)	(60.4M)	(63.5M)
Accounts Payable	156.0K	2.5M	1.4M	806.0K	870.2K	1.0M
Cash	1.6M	39.1M	9.6M	13.4M	5.8M	5.5M
Non Current Assets Total	45.8K	189.4K	819.6K	928.7K	720.4K	684.4K
Cash And Short Term Investments	1.6M	39.1M	26.4M	13.4M	5.8M	5.5M
Common Stock Shares Outstanding	486.2K	4.1M	8.3M	8.4M	9.4M	9.8M
Liabilities And Stockholders Equity	1.8M	40.6M	28.1M	14.9M	7.3M	7.0M
Non Current Liabilities Total	1.4M	156.0K	72.9K	1.5M	73.3K	0.0
Other Current Assets	94.5K	1.2M	892.3K	633.2K	831.6K	590.6K
Other Stockholder Equity	7.7M	51.5M	54.4M	57.4M	64.3M	90.4M
Total Liab	2.0M	4.7M	3.4M	2.8M	3.4M	3.9M
Total Current Assets	1.7M	40.4M	27.2M	14.0M	6.6M	6.3M
Non Currrent Assets Other	44.4K	16.5K	738.3K	754.7K	638.3K	1.0M

Additional Tools for Indaptus Stock Analysis

When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Indaptus Net Debt vs Short Long Term Debt Total Analysis

Net Debt vs Short Long Term Debt Total

Net Debt vs Short Long Term Debt Total Correlation Analysis

Correlation Coefficient

Net Debt

Short Long Term Debt Total

Indaptus Therapeutics fundamental ratios Correlations

Indaptus Therapeutics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Indaptus Therapeutics fundamental ratios Accounts

Additional Tools for Indaptus Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.98	Total Assets
Cash And Short Term Investments	+ 0.98	Total Stockholder Equity
Total Current Assets	+ 0.98	Total Stockholder Equity
Property Plant Equipment	+ 0.98	Net Tangible Assets

Cash	- 1.0	Net Debt
Total Current Assets	- 0.97	Net Debt
Cash And Short Term Investments	- 0.97	Net Debt
Other Stockholder Equity	- 0.96	Retained Earnings
Net Debt	- 0.95	Total Stockholder Equity
Net Debt	- 0.95	Total Assets